11th Annual Outsourcing in Clinical Trials UK and Ireland 2024

Welcome to 11th annual Outsourcing in Clinical Trials UK and Ireland 2024

11 - 12

June

2024
  • London Hilton on Park Lane, UK
  • Complimentary
  • Why attend?
  • Agenda
  • Speakers
  • Plan Your Visit
  • Event Gallery
  • Sponsors
  • Media Centre
  • Why partner?
  • Contact Us
close

Why attend?

WHAT TO EXPECT FOR 2024?

This exclusive event brings together attendees from established pharma, large and small, alongside with biopharmaceutical companies and gives opportunity to dive into the operational challenges and innovations in clinical development found within the UK & Ireland region.

200+

Attendees

50+

Exhibitors

40+

Speakers

200+

Attendees

50+

Exhibitors

40+

Speakers

See What It's All About

Agenda

  • 11 Jun 2024
  • 12 Jun 2024
Expand All

Streams

Stream one

STREAM A: Clinical Operations and Outsourcing

Stream two

STREAM B: Clinical Technology and Innovation

11 AM

Morning refreshments and networking

11:30 AM

Case study: Redefining clinical data flow

Sharing experiences from a holistic change of systems and processes including: data collection, data standardization, flow into AstraZeneca, data management, medical and safety review, data analysis and reporting, and long term data retention

Speakers

Lucy Moore
Executive Director, Clinical Data Projects, Clinical Data and Insights, AstraZeneca

12 PM

Reserved for event sponsor

12:30 PM

Selecting and utilising digital health technologies in clinical trials

·       Understanding how digital technologies can provide wider access to trials

·       Reviewing digital technologies and data they can reliably collect

·       Planning incorporation of digital technologies into trial design

·       Considering benefits and challenges of digital technologies

Speakers

Guilherme Safioti
Senior Director Respiratory and Digital Health, Global Medical Affairs, Teva

1 PM

Reserved for event sponsor

1 PM

Lunch and networking

2:30 PM

Vaccine Trial – what we have learnt and what could be used more widely?

·       Brief overview of innovations used to improve the set-up and performance of vaccine studies

·       Focus on innovations that could be more widely utilised for:

o   Investigators

o   Sites

o   Placement

o   Recruitment

o   Set-up & Agreements

Speakers

Andrew Ustianowski
Network Director, upcoming North West Regional Research Delivery Network, NIHR

3 PM

Reserved for event sponsor (tech spotlight)

3:15 PM

Reserved for event sponsor (tech spotlight)

3:30 PM

Panel Discussion: Exploring data management tools and technologies that can assist in clinical trials

·       Discussing technologies and tools available for use in clinical trial

·       Outlining the risks and rewards of data management tools and technologies

·       Explaining how to implement: providing examples of successes and lessons learnt

Speakers

Lucy Moore
Executive Director, Clinical Data Projects, Clinical Data and Insights, AstraZeneca
Guilherme Safioti
Senior Director Respiratory and Digital Health, Global Medical Affairs, Teva

8 AM

Registration and refreshments

8:50 AM

Chairperson’s opening remarks

Speakers

Priya Nair
Senior Analyst, GlobalData

9 AM

Keynote: Latest overview of UK clinical trial landscape: are we achieving the ambition?

·       Progression so far since the clinical trial review

·       Further improvements and plans to achieve them

·       Outlook for the future of UK clinical trials

Speakers

Professor Lucy Chappell
Chief Scientific Adviser, Department of Health and Social Care

9:30 AM

Panel discussion and audience Q&A: Reviewing recent improvements to UK clinical trial landscape and future actions for continued success

·       Discussing positive progress made in the UK since the clinical trial review in May 2023

·       Considering ongoing challenges and future actions required

·       Hearing viewpoints on where we are now from experience on the ground

Speakers

Prof Lucy Chappell
Chief Scientific Adviser, Department of Health and Social Care
Lord James O’Shaughnessy
Member of the House of Lords, former Health Minister, Senior Partner at Newmarket Strategy
Andrew Ustianowski
Network Director, upcoming North West Regional Research Delivery Network, NIHR
Janet Valentine
Executive Director Innovation and Research Policy, ABPI

10 AM

Reserved for event sponsor

10:30 AM

Reserved for event sponsor

11 AM

Morning refreshments and networking

11:30 AM

Finding the right balance between the needs of sponsor company and vendor to ensure right fit

·       Integrating vendors and silos into your own organization

·       Where does vendor management end and vendor oversight start?

·       Creating the right framework for a long-lasting partnership

Speakers

Craig Elliott
Director Alliance Management and Sourcing, Merck

12 PM

Reserved for event sponsor

12:30 PM

Incorporating sustainability in clinical trials to improve ESG responsibilities

·       Healthcare sector’s responsibility and action to address the climate crisis as accelerator for the health crisis

·       Methodology and available tools to assess carbon footprint of clinical trials

·       Clinical best-practices to save significant natural and financial resources

·       Incorporating sustainability endpoints into clinical trials

Speakers

Ashton Harper
Head of Medical Affairs, Access & Innovation, Roche

1 PM

Reserved for event sponsor

1:30 PM

Lunch and networking

2:30 PM

Panel Discussion: Negotiating vendor agreements: getting the right balance for both sponsor and vendor

·       Finding the right balance between the needs of sponsor company and vendor to ensure right fit

·       Negotiating contracts: costs vs vendor ability to perform

·       Forging partnerships and relationships to enhance contract negotiations and communication

Moderator:  Priya Nair, Senior Analyst, GlobalData

Speakers

Priya Nair
Senior Analyst, GlobalData
Rachael McTegart
Contracts and Outsourcing Director, Barinthus Biotherapeutics
Craig Elliott
Director Alliance Management and Sourcing, Merck

3 PM

Reserved for event sponsor

3:30 PM

Panel discussion: Overcoming site start-up delays and maximizing site productivity

·       Managing timelines for CTA sign off to avoid bottlenecks

·       Aligning team involvement for responsibilities and oversight

·       Addressing current challenges sites are facing

Moderator:  Priya Nair, Senior Analyst, GlobalData

Speakers

Priya Nair
Senior Analyst, GlobalData
Fiona Shields
Study and Site Operations Country Head (UK), Novartis
Yinka Cole
Associate Director, Clinical Data and Site Operations, Adaptimmune
Andrew Ustianowski
Network Director, upcoming North West Regional Research Delivery Network, NIHR
Val Jarvis-Evans
Director Clinical Site Operations (UK & Netherlands), Global Site & Study Operations, Pfizer

4 PM

Afternoon refreshments and networking

4:30 PM

Reserved for event sponsor

5 PM

Closing Keynote: MHRA Update

·       Overview of the work conducted since July 2023

·       Implementation and sustainability of performance

·       New clinical trials operating model

Speakers

Andrea Manfrin
Deputy Director of Clinical Investigations

5:30 PM

Chairperson’s closing remarks

Speakers

Priya Nair
Senior Analyst, GlobalData

END OF DAY 1 AND NETWORKING DRINKS RECEPTION

Streams

Stream one

STREAM A: Clinical Operations and Outsourcing

Stream two

STREAM B: Clinical Technology and Innovation

11:30 AM

Implementing digital health technologies into clinical trials

·       What is Digital Health?

·       How can Digital Health Technologies be used in Clinical Development?

  • Challenges and opportunities
  • Process for selection and implementation

Speakers

Farrell Healion
Senior Director, Emerging Technology, Global Clinical Solutions, AstraZeneca

12 PM

Reserved for event sponsor

12:30 PM

Lunch and networking

1:30 PM

Panel Discussion: Innovative thinking for increasing patient diversity and inclusion in clinical trials

Whilst diversity has been a hot topic for some time, it remains of key importance to improve in the UK

·       Ensuring diversity in medical research: how are we progressing?

·       Increasing diversity in clinical trial patient recruitment

·       Advancing medicine through increased diversity

Panellists:

HRA Representative

Ken Chow, Health Tech Counsel, Flanders

Speakers

Ken Chow
Health Tech Counsel, Flanders

2 PM

Using generative AI in clinical trials to transform drug development by automating tasks, improving accuracy and generating new insights

·       What is generative AI and what are the benefits and challenges?

·       Using generative AI in protocol writing

·       Leveraging machine learning algorithms to generate and optimize potential drug candidates

8 AM

Registration and refreshments

8:50 AM

Chairperson’s opening remarks

Speakers

Priya Nair
Senior Analyst, GlobalData

9 AM

Keynote: Clinical trial review – one year on, where are we now?

In May 2023, Lord James O’Shaughnessy published an independent review of commercial clinical trials in the UK, commissioned by the Government. Since the review, the UK have been responding to action his recommendations on how commercial clinical trials can help the life sciences sector unlock UK growth and investment opportunities and resolve key challenges in conducting commercial clinical trials in the UK. Lord James O’Shaughnessy returns this year to provide an update on where the UK are at, one year on since his review.

Speakers

Lord James O’Shaughnessy
Member of the House of Lords, former Health Minister, Senior Partner at Newmarket Strategy

9:30 AM

Reserved for event sponsor

10 AM

Informing on Clinical Trial Regulation landscape: latest and upcoming updates

·       Overview of the latest and upcoming changes to CTR

·       Outlining changes to systems and how this will help

·       Insights into HRA strategy

Speakers

Dr Janet Messer
Director of Approvals, HRA

10:30 AM

Reserved for event sponsor

11 AM

Morning refreshments and networking

11:30 AM

Maintaining financial oversight of clinical studies to continue development and optimise costs

·       Budgeting effectively in challenging financial market

·       Creating a cost optimized study design to work more financially effectively

·       Maintaining financial oversight and control over your clinical study budget

Speakers

Alecia Barry
Executive Director, Franchise Head – Breast, GYN & GU Indications, Oncology Clinical Operations, Gilead

12 PM

Reserved for event sponsor

12:30 PM

Lunch and networking

1:30 PM

Reserved for GlobalData

Speakers

Scotty Chung-Siu
Managing Analyst, Clinical Trials Intelligence, GlobalData

2 PM

Case study: Utilising academic and industry collaborations for PPI in clinical trials

·       Overview of the drug used in the clinical trial

·       Integrating and increasing PPI through academic and industry collaboration

·       Highlighting the value of PPI on trial design, recruitment and retainment

Speakers

Julia DeCesare
Senior Director, Clinical Operations, Accession Therapeutics
Dave Cole
Head of Research, Accession Therapeutics
Joanna Zabkiewicz
Senior Research Fellow, Cardiff University
Angela Harris
Executive Officer, School of Medicine, Cardiff University

2:30 PM

The patient journey when participating in a clinical trial

·       What do patients experience when participating in a clinical trial from start to finish?

·       Understanding patients’ motivations for choosing and staying in a clinical trial

·       Hurdles and barriers to patients’ participation in clinical trials: what can companies do to improve this and relieve burden on patients?

·       How can technology both help and hinder patients’ engagement in clinical trials?

Speakers

Rebecca Mbewe
Patient Advocate

3 PM

Afternoon refreshments, networking, and Apple Prize Draw

3:30 PM

ROUNDTABLE SESSIONS

During the roundtable discussion session, the conference hall will be divided into zones. Delegates can choose which zone they would like to join. Each zone will be led by a table lead/host and will focus on a different challenge within the industry. After 30 minutes, delegates will have the opportunity to swap and choose a different table, and each roundtable will run twice.

ROUNDTABLE 1

Re-evaluating study if things go wrong with CRO or country in clinical trial: to stay or change?

Alison McMorn, VP Clinical Development, AMO Pharma

ROUNDTABLE 2

Comprehending the latest rules on patient information sheet submission

HRA Representative

ROUNDTABLE 3

Considerations for cell and gene therapy trials set up

Yinka Cole, Associate Director, Clinical Data and Site Operations, Adaptimmune

Speakers

Dr Alison McMorn
PH.D – VP, CLINICAL DEVELOPMENT, AMO PHARMA LTD
Yinka Cole
Associate Director, Clinical Data and Site Operations, Adaptimmune

4:30 PM

Chairperson’s closing remarks

Speakers

Priya Nair
Senior Analyst, GlobalData

END OF CONFERENCE

Speakers

Select a speaker to learn more

Back
Lord James O’Shaughnessy
Member of the House of Lords, former Health Minister, Senior Partner at Newmarket Strategy

James has operated at the highest levels of government, including as a Minister at the
Department for Health & Social Care, as Director of the No.10 Policy Unit, and as an advisor to
DHSC Ministers during the COVID-19 crisis. As Minister his responsibilities included
implementing the Life Science Industrial Strategy, delivering a new pricing scheme with the
pharmaceutical industry, chairing the National Genomics Board, and driving the digital
transformation of the NHS. He was also responsible for preparing the health and social care
sectors for Brexit and helping to design the post-Brexit regulatory regime.

James is co-founder and Senior Partner of Newmarket Strategy, a consultancy dedicated to
improving access to health innovation by providing strategic advice and technical support to
the healthcare, life sciences and health tech sectors. He is also a non-executive director at
HDR-UK and the Albion Development VCT plc. In early 2023 James was commissioned by the
Government to carry out an independent review of commercial clinical trials in the UK, which
was published in May.

 

Session Details:

Panel discussion and audience Q&A: Reviewing recent improvements to UK clinical trial landscape and future actions for continued success

2024-06-11, 9:30 AM

Session Details:

OPENING KEYNOTE: CLINICAL TRIAL REVIEW

2023-09-06, 9:00 AM

Session Details:

Keynote: Clinical trial review – one year on, where are we now?

2024-06-12, 9:00 AM

View In Agenda
Next speaker
Back
Prof Lucy Chappell
Chief Scientific Adviser, Department of Health and Social Care

Session Details:

Panel discussion and audience Q&A: Reviewing recent improvements to UK clinical trial landscape and future actions for continued success

2024-06-11, 9:30 AM

View In Agenda
Next speaker
Back
Andrew Ustianowski
Network Director, upcoming North West Regional Research Delivery Network, NIHR

Professor Andrew Ustianowski is a Consultant Physician in Infectious Diseases at the Regional Infection Unit, North Manchester General Hospital, UK, and from April 2024 the Network Director for the NW Regional Research Delivery Network, National Institute of Health Research (NIHR). Other roles include: the joint National Specialty Lead for Infection (NIHR); co-Clinical Director for the Greater Manchester Clinical Research Network; Clinical Lead for the Manchester Academic Health Science Centre; National Clinical Lead for the UK NIHR COVID Vaccine Research Programme; and joint National Clinical Lead for the UK’s Vaccine Innovation Pathway. He has been UK chief investigator on multiple COVID, HIV and other studies and PI on >100 other trials.

Prof Ustianowski graduated from Guy’s Hospital, London, UK and subsequently trained in Infectious Diseases, Tropical Medicine, HIV and General Medicine in the London region

Session Details:

Panel discussion and audience Q&A: Reviewing recent improvements to UK clinical trial landscape and future actions for continued success

2024-06-11, 9:30 AM

Session Details:

Panel discussion: Overcoming site start-up delays and maximizing site productivity

2024-06-11, 3:30 PM

Session Details:

Vaccine Trial – what we have learnt and what could be used more widely?

2024-06-11, 2:30 PM

View In Agenda
Next speaker
Back
Janet Valentine
Executive Director Innovation and Research Policy, ABPI

Session Details:

Panel discussion and audience Q&A: Reviewing recent improvements to UK clinical trial landscape and future actions for continued success

2024-06-11, 9:30 AM

View In Agenda
Next speaker
Back
Andrea Manfrin
Deputy Director of Clinical Investigations

Session Details:

Closing Keynote: MHRA Update

2024-06-11, 5:00 PM

View In Agenda
Next speaker
Back
Dr Janet Messer
Director of Approvals, HRA

Experienced strategic leader with extensive experience of operations, business transformation and introducing digital systems. Systems-thinker with focus on delivering cross-sector improvement. Deep knowledge of health and care research regulation and governance.

Session Details:

Informing on Clinical Trial Regulation landscape: latest and upcoming updates

2024-06-12, 10:00 AM

View In Agenda
Next speaker
Back
Julia DeCesare
Senior Director, Clinical Operations, Accession Therapeutics

Session Details:

Case study: Utilising academic and industry collaborations for PPI in clinical trials

2024-06-12, 2:00 PM

View In Agenda
Next speaker
Back
Dave Cole
Head of Research, Accession Therapeutics

Session Details:

Case study: Utilising academic and industry collaborations for PPI in clinical trials

2024-06-12, 2:00 PM

View In Agenda
Next speaker
Back
Yinka Cole
Associate Director, Clinical Data and Site Operations, Adaptimmune

Session Details:

Panel discussion: Overcoming site start-up delays and maximizing site productivity

2024-06-11, 3:30 PM

Session Details:

ROUNDTABLE SESSIONS

2024-06-12, 3:30 PM

View In Agenda
Next speaker
Back
Dr Alison McMorn
PH.D – VP, CLINICAL DEVELOPMENT, AMO PHARMA LTD

Dr. McMorn is an experienced clinical development researcher with over 25 years of industry experience and has a strong focus in CNS and paediatric drug development. She has worked for both Pharmaceutical Companies and Contract Research Organisations including holding positions at SAR Monitoring Services Ltd, Mundipharma International Ltd and Shire Development Inc. Starting her career at SAR as a Clinical Research Associate (CRA) she subsequently moved to Mundipharma where she was responsible for initiating the first paediatric clinical research program for the company. At Shire Dr. McMorn led, planned and managed global paediatric and adult clinical development programs for a wide variety of indications including psychiatry, pain, gastrointestinal and hepatology across all phases of development (Phase 0 to Phase 4). In addition she was responsible for harmonizing Clinical Trial Administrator (CTA) working practices across all regions for the company. In 2015 Dr. McMorn joined AMO Pharma Ltd, a virtual pharmaceutical company focused predominantly on paediatric neurodevelopmental rare diseases, as VP of Clinical Development. She holds an undergraduate degree in Pharmacology and a PhD in Psychology from the University of Leeds, UK.

Session Details:

ROUNDTABLE SESSIONS

2024-06-12, 3:30 PM

View In Agenda
Next speaker
Back
Lucy Moore
Executive Director, Clinical Data Projects, Clinical Data and Insights, AstraZeneca

Session Details:

Case study: Redefining clinical data flow

2024-06-11, 11:30 AM

Session Details:

Panel Discussion: Exploring data management tools and technologies that can assist in clinical trials

2024-06-11, 3:30 PM

View In Agenda
Next speaker
Back
Farrell Healion
Senior Director, Emerging Technology, Global Clinical Solutions, AstraZeneca

Session Details:

Implementing digital health technologies into clinical trials

2024-06-12, 11:30 AM

View In Agenda
Next speaker
Back
Rachael McTegart
Contracts and Outsourcing Director, Barinthus Biotherapeutics

Session Details:

Panel Discussion: Negotiating vendor agreements: getting the right balance for both sponsor and vendor

2024-06-11, 2:30 PM

View In Agenda
Next speaker
Back
Joanna Zabkiewicz
Senior Research Fellow, Cardiff University

Session Details:

Case study: Utilising academic and industry collaborations for PPI in clinical trials

2024-06-12, 2:00 PM

View In Agenda
Next speaker
Back
Angela Harris
Executive Officer, School of Medicine, Cardiff University

Session Details:

Case study: Utilising academic and industry collaborations for PPI in clinical trials

2024-06-12, 2:00 PM

View In Agenda
Next speaker
Back
Alecia Barry
Executive Director, Franchise Head – Breast, GYN & GU Indications, Oncology Clinical Operations, Gilead

Session Details:

Maintaining financial oversight of clinical studies to continue development and optimise costs

2024-06-12, 11:30 AM

View In Agenda
Next speaker
Back
Scotty Chung-Siu
Managing Analyst, Clinical Trials Intelligence, GlobalData

Session Details:

Reserved for GlobalData

2024-06-12, 1:30 PM

View In Agenda
Next speaker
Back
Priya Nair
Senior Analyst, GlobalData

Session Details:

Chairperson’s opening remarks

2024-06-11, 8:50 AM

Session Details:

Panel Discussion: Negotiating vendor agreements: getting the right balance for both sponsor and vendor

2024-06-11, 2:30 PM

Session Details:

Panel discussion: Overcoming site start-up delays and maximizing site productivity

2024-06-11, 3:30 PM

Session Details:

Chairperson’s closing remarks

2024-06-12, 4:30 PM

Session Details:

Chairperson’s opening remarks

2024-06-12, 8:50 AM

Session Details:

Chairperson’s closing remarks

2024-06-11, 5:30 PM

View In Agenda
Next speaker
Back
Ken Chow
Health Tech Counsel, Flanders

Session Details:

Panel Discussion: Innovative thinking for increasing patient diversity and inclusion in clinical trials

2024-06-12, 1:30 PM

View In Agenda
Next speaker
Back
Craig Elliott
Director Alliance Management and Sourcing, Merck

Session Details:

Finding the right balance between the needs of sponsor company and vendor to ensure right fit

2024-06-11, 11:30 AM

Session Details:

Panel Discussion: Negotiating vendor agreements: getting the right balance for both sponsor and vendor

2024-06-11, 2:30 PM

View In Agenda
Next speaker
Back
Fiona Shields
Study and Site Operations Country Head (UK), Novartis

Fiona is an experienced Clinical research Professional who has 25+ years of extensive experience in different roles of Clinical Trial Operations. Starting her career as an Oncology Nurse she moved into Clinical Research to support the development of Clinical Trial delivery at the Leicester Royal Infirmary which then became part of the National Cancer Research Network. Moving her career forward she has undertaken a variety of roles, in CROs, Pharma and Medical Device companies concentrating on the building of trial Operation Services.

In her current role,  Country Head ( UK), Study and Site Operations,  within Novartis Fiona is accountable for all country clinical operations and has a responsibility to drive the strategic direction of the study and site operations department. She  manages a team of accomplished leaders to increase the contribution that Novartis can make within the Clinical Trial landscape.

Throughout her career Fiona has always had a passion for people leadership and applies this in her management and leadership style.

Session Details:

Panel discussion: Overcoming site start-up delays and maximizing site productivity

2024-06-11, 3:30 PM

View In Agenda
Next speaker
Back
Rebecca Mbewe
Patient Advocate

Session Details:

The patient journey when participating in a clinical trial

2024-06-12, 2:30 PM

View In Agenda
Next speaker
Back
Val Jarvis-Evans
Director Clinical Site Operations (UK & Netherlands), Global Site & Study Operations, Pfizer

Session Details:

Panel discussion: Overcoming site start-up delays and maximizing site productivity

2024-06-11, 3:30 PM

View In Agenda
Next speaker
Back
Ashton Harper
Head of Medical Affairs, Access & Innovation, Roche

Session Details:

Incorporating sustainability in clinical trials to improve ESG responsibilities

2024-06-11, 12:30 PM

View In Agenda
Next speaker
Back
Guilherme Safioti
Senior Director Respiratory and Digital Health, Global Medical Affairs, Teva

Session Details:

Selecting and utilising digital health technologies in clinical trials

2024-06-11, 12:30 PM

Session Details:

Panel Discussion: Exploring data management tools and technologies that can assist in clinical trials

2024-06-11, 3:30 PM

View In Agenda
Next speaker

Plan Your Visit

Venue

London Hilton on Park Lane

22 Park Lane W1K 1BE London United Kingdom

Accommodation

Please be aware that should you be contacted by any 3rd party housing companies that they are not affiliated with us or the hotel.

Sponsors

Select a sponsor to learn more

FEATURED SPONSORS

SESSION SPONSORS

EXHIBITORS

CO-SPONSORS

Why partner?

Contact us to become a partner

Partnership Opportunities

We work with you to design a bespoke package to meet your business needs, where you could:

  • Demonstrate your expertise on the agenda – have the attention of the entire audience. For greatest impact, why not position your talk before a networking break and immediately conduct follow up conversations with highly engaged attendees
  • Showcase your business and its services at an exhibition booth, which provides a perfect meeting place for prospective new clients
    Present the value proposition of your offering over your competitors, in front of an audience of active, engaged potential customers
  • Speak with key decision makers as part of our intimate, interactive roundtable style workshop sessions with over 8 hours allowed for networking

Event reach

  • 150+ attendees each year
  • 80% attendees C-suite level

 

Take a look at our current sponsors

Media Centre

Media Partners

Become A Media Partner

See What It's All About

Enquiry

Contact Us

SPONSORSHIP ENQUIRIES

Ben Lloyd-Davis

Head of Healthcare Sponsorship

+44 207866 9497

SPEAKING OPPORTUNITIES

Maya Hudson

Senior Conference Producer

MARKETING ENQUIRIES

Moona Popal

Marketing Manager

DELEGATE ENQUIRIES

Sunny Saikia

VIP Delegate Manager

SPONSORSHIP ENQUIRIES

To enquire about sponsorship opportunities for the conference, please contact:

Ben Lloyd-Davis

Head of Healthcare Sponsorship


+44 207866 9497

SPEAKER ENQUIRIES

To enquire about speaking opportunities for the conference, please contact:

Maya Hudson

Senior Conference Producer


+44 (0) 204 540 7766